Blog
Bem-vindo ao nosso blog - seu novo canal de informações para notícias, lançamento de produtos, artigos científicos, estudos de caso e muito mais.
View all blogs:
Introducing new bioprocessing solutions to replace banned materials
We have introduced a critical range of new bioprocessing detergents optimised for viral inactivation and cell lysis. The company’s new product range, Virodex™, offers an answer to the key market need...
Cholesterol: enhancing stability and efficacy in lipid-based drug delivery
Cholesterol, a key component in lipid-based drug delivery systems, provides structural support and stability, enhances the efficiency of intracellular delivery and gene transfection.
Acquisition of Solus Biotech expands specialised Pharma business in Asia
05 July 2023: Croda International Plc (‘Croda’) announced that it has acquired Solus Biotech, a global leader in premium, biotechnology-derived materials, from Solus Advanced Materials
Acquisition of Solus Biotech strengthens Croda Pharma
On 04 July Croda successfully completed the acquisition of Solus Biotech, an innovative biotechnology company with over three decades of industry experience.
Croda opens new Global Technical Centre at Genome Valley, Hyderabad, India
PRESS RELEASE – On June 21, 2023, Croda International Plc opened its new Global Technical Centre at Genome Valley, Hyderabad, India.
Croda breaks ground on new manufacturing facility for pharmaceutical excipients in Lamar, Pennsylvania
31st May 2023: Croda, Inc., the company that uses smart science to create high-performance ingredients and solutions that improve lives, broke ground on 9 May 2023, its newest manufacturing facility...
From Triton X-100 to Virodex: exploring our innovative solution to the Triton X-100 ban
For those who have previously relied on Triton™ X-100 as a surfactant or detergent in their manufacturing processes there is now an urgent need to find a suitable replacement. Explore Croda's...
Promising new results for metastatic prostate cancer vaccine
A new study published in Frontiers in Immunology reports promising vaccine results for patients with hormone-sensitive prostate cancer. The researchers, including Croda’s Head of Global Research &...
Croda announces two new partnerships to drive sustainable delivery systems for the pharmaceutical industry
19 May 2023: Croda International Plc (Croda) today announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply chain...
Expert Q&A - Dr Stephen Rumbelow:
Formulating a drug for parenteral delivery comes with its fair set of challenges. Aside from a high level of sensitivity to external factors like light and heat exposure, these large and complex drugs...
Oral drug delivery
The oral route of administration presents a convenient, cost-effective, and non-invasive method for delivering drugs. However, with the increasing complexity of APIs, the delivery of these drugs also...
Revolutionizing gene editing: How RGD peptide-based lipids could be the key to effective mRNA delivery
Gene editing has emerged as a promising strategy for treating a wide range of genetic disorders. However, the efficacy of gene therapy is limited by the challenge of delivering therapeutic agents to...
Precision medicine revolution: The potential of DSPE-RGD in targeted drug delivery
In recent years, researchers and clinicians have been exploring new ways to deliver drugs directly to the cells and tissues that need them, while minimizing side effects on healthy cells. One of the...
Consumer Health at Croda Pharma - over 100 years of heritage
For the Consumer Health team, our main goal is to help our customers market consumer relevant claims that grow their product and brand authority.
Croda Pharma welcomes Dave Cherry
We warmly welcome Dave Cherry as our new Global Managing Director. David brings with him past experiences from his work with the wider Life Sciences Leadership Team and healthcare markets, which is...
Lipids in small molecule pro drugs
Lipids are used in therapeutics in many ways. Some lipids have even been used as small-molecule drugs to treat specific diseases, and are also being used to improve undesirable characteristics of...
Our veterinary health offering
We are the global partner for high quality excipients, adjuvant systems and formulation support for the animal health industry, and we are continuously innovating to provide break-through solutions...
Introducing our Nucleic Acid Delivery platform
This post introduces our Nucleic Acid Delivery platform, a technology area that was strengthened through our acquisition of Avanti Polar Lipids in 2020.
Croda Pharma: The future of novel excipients
The importance of excipients and their specialised role in formulation development has been recognised in recent years, whether that be for targeting delivery of the drug, aesthetics of the final...
Lipid technology for delivery of gene editing therapies
Gene-editing is one of the most eagerly anticipated biopharma developments in recent history. However, one of the biggest hurdles to the development of successful gene-editing therapeutics is...